Covington Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-852
Closed -$157K 1070
2021
Q2
$157K Buy
852
+695
+443% +$119K 0.01% 387
2021
Q1
$24K Buy
157
+7
+5% +$1.08K ﹤0.01% 579
2020
Q4
$23K Hold
150
﹤0.01% 569
2020
Q3
$17K Hold
150
﹤0.01% 575
2020
Q2
$17K Hold
150
﹤0.01% 576
2020
Q1
$13K Sell
150
-230
-61% -$22.6K ﹤0.01% 584
2019
Q4
$41K Sell
380
-162
-30% -$17.3K ﹤0.01% 501
2019
Q3
$53K Hold
542
﹤0.01% 438
2019
Q2
$71K Buy
542
+53
+11% +$6.83K ﹤0.01% 390
2019
Q1
$66K Buy
489
+31
+7% +$3.85K ﹤0.01% 387
2018
Q4
$45K Hold
458
﹤0.01% 439
2018
Q3
$64K Hold
458
﹤0.01% 398
2018
Q2
$57K Hold
458
﹤0.01% 412
2018
Q1
$51K Hold
458
﹤0.01% 427
2017
Q4
$55K Buy
458
+97
+27% +$11.8K ﹤0.01% 445
2017
Q3
$51K Buy
+361
New +$49K ﹤0.01% 432

Other funds holding ALXN